ABVC ABVC BioPharma Inc
3,807
$0.88
$0.0451
(4.88%)
| Watchers | 3,807 |
| 52-Wk Low | $0.6739 |
| 52-Wk High | $7.04 |
| Market Cap | $10.15M |
| Volume | 167,977.00 |
| 52-Wk High | $7.04 |
| 52-Wk Low | $0.6739 |
Biotech Companies Making Strides in Pancreatic Cancer Treatment and Early DetectionPR Newswire • 14 days ago
Biotech Companies Making Strides in Pancreatic Cancer Treatment and Early Detection Biotech Companies Making Strides in Pancreatic Cancer Treatment and Early Detection PR Newswire VANCOUVER, BC, May...
Share to Feed
ABVC BioPharma, Inc. (NASDAQ:ABVC Get Free Report) was the recipient of a significant decrease in short interest during the month of March. As of March 15th, there was short interest...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
FREMONT, CA, March 26, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in...
ABVC BioPharma said that the licensing agreement includes the ophthalmology pipeline, including the medical device Vitargus licensed products' and clinical trial, registration, manufacturing, supply...
FREMONT, CA, March 21, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in...
FREMONT, CA, March 19, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in...
FREMONT, CA, March 14, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (NASDAQ: ABVC) ( Company ), a biotechnology company specializing in botanically based solutions that deliver...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
FREMONT, CA, Feb. 27, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in...